Skip to content
MO

Altria Group, Inc.

Altria Group, Inc. Q4 FY2025 earnings call

January 29, 2026 · fiscal period ended 2025-12

EPS · actual vs est

$1.30 / $1.32Miss -1.5%

Revenue · actual vs est

$5.85B / $5.03BBeat +16.2%
Ask about this call

Summary

Generated 2026-01-29

Management highlights

  • U.S. Nicotine Space: Estimated 30 million adult consumers in e-vapor and oral tobacco categories. Smoke-free alternatives over 50% of nicotine space. Illicit flavored disposable e-vapor products a major headwind. FDA actions needed for better regulatory clarity.
  • Nicotine Pouch Category: Oral tobacco volume up 14% past 6 months. ON! grew shipment volume. ON PLUS launched, with plans for national rollout in first half of 2026. Positive consumer feedback on ON PLUS's pouch material and flavor.
  • International Smoke-free Efforts: ON PLUS and Fumi in international markets, expanding to 40,000 retail locations in seven markets. Added new line extensions for Fumi.
  • 2026 Financial Outlook: Expect 2026 full-year adjusted diluted EPS in range of $5.56 to $5.72, weighted to second half, reflecting planned investments and NJOY ACE not returning to market.
View in transcript ↓

Segment performance

Smokeable Products Segment: Full year adjusted operating income (OCI) exceeded $11 billion, with adjusted OCI margins expanding 1.8 percentage points to 63.4%. In the fourth quarter, adjusted OCI declined 2.4% and margins contracted 0.8 percentage points to 60.4%. Domestic cigarette volumes decreased. Discount segment growth impacted Marlboro's retail share, while Marlboro remained leader in premium segment. Cigars: Middleton outperformed.

Oral Tobacco Products Segment: Fourth quarter adjusted OCI declined 4.6%, with margins contracting 5 percentage points to 64.5%. Full year adjusted OCI increased 1.3%, with margins modestly expanding 0.1 percentage points to 67.9%. Total segment reported shipment volume decreased, but ON! growth partially offset declines.

E-vapor Reporting Unit: Impairment charges of $1.3 billion recorded in Q4 due to lack of meaningful reduction in illicit e-vapor volumes despite increased enforcement. Reporting segments updated to include e-vapor products segment (NJOY business).

View in transcript ↓

Guidance

  • 2026 full-year adjusted diluted EPS expected in range of $5.56 to $5.72, representing 2.5%-5.5% growth from 2025's $5.42 base.
  • Growth weighted to second half, reflecting progressive increase in cigarette import and export activity.
  • Guidance contemplates planned investments, limited impact from illicit enforcement on combustible/e-vapor volumes, and NJOY ACE not returning in 2026.
View in transcript ↓

Risks

  • Proliferation of illicit flavored disposable e-vapor products jeopardizing tobacco harm reduction opportunity.
  • Pace of FDA market authorizations for smoke-free products remains a concern.
  • Intellectual property landscape poses challenges to product development and market entry.
View in transcript ↓

Q&A highlights

Q: Can you provide color on the scope of the import-export program for 2026?

A: A bit reluctant to share specifics, but upfront investments are moderate, allowing duty drawback and setting up manufacturing for international markets.

Q: Is the elevated CapEx in 2026 a one-time increase?

A: Primary driver is investments for import-export business, not a one-time increase, with investments preceding volume and related to long-term vision.

Q: Thoughts on aggressive promotional strategy behind Basic weighing on net price realization?

A: Basic deployed in ~30,000 stores, targeting consumers under economic pressure, with revenue growth management analytics applied, and not seen as competitive to Marlboro strategy.

Q: Any commentary on increased smoking incense among younger legal-aged users?

A: No specific trends seen, and focus is on expediting FDA authorization of smoke-free products to inform consumers.

Q: Why start ON PLUS distribution in three states initially?

A: Initially started in three states as Salesforce had existing distribution, with plans for national rollout in first half of 2026.

Q: Clarification on pricing of competitors in nicotine pouches?

A: Significant competitor promotions in third and fourth quarters, including free cans with purchases, impacting competitive pricing, while ON Classic saw price increases.

Q: Payback time for import-export investment?

A: Payback is less than a year, with strong return on investment. Elevated investments upfront as volume increases through import-export process

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$1.30$1.32-1.5%$1.29
Revenue$5.85B$5.03B+16.2%$5.11B

Transcript

January 29, 2026

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.